4//SEC Filing
Langren Carl W. 4
Accession 0001126234-21-000043
CIK 0001126234other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 5:47 PM ET
Size
6.6 KB
Accession
0001126234-21-000043
Insider Transaction Report
Form 4
LUMOS PHARMA, INC.(LUMO)
Langren Carl W.
Principal Accounting Officer
Transactions
- Tax Payment
Common Stock
2021-04-01$12.25/sh−683$8,367→ 11,494 total
Holdings
- 5,521(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 2,250 previously reported restricted stock units ("RSUs") granted to the Reporting Person.
- [F2]Includes 939 RSUs previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments with the next installment occurring on February 1, 2022, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- [F3]Includes 6,750 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on April 1, 2022, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
Documents
Issuer
LUMOS PHARMA, INC.
CIK 0001126234
Entity typeother
Related Parties
1- filerCIK 0001591245
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 5:47 PM ET
- Size
- 6.6 KB